With a growing shortage of cardiologists in the U.S., there is growing interest recruiting more clinicians from overseas. But there are barriers to this, approach explained Abdel Almanfi, MD, FACC, FSCAI, a structural heart interventional cardiologist at Baylor St. Luke's Medical Center in Houston, Texas. He spoke with Cardiovascular Business and shared his journey from Libya to the United States, shedding light on the challenges foreign doctors face in realizing their dreams of practicing in America.

Cardiologist shares his long journey from Libya to United States

Abdel Almanfi, MD, went through years of training in Libya, but then he had to start over once he landed in the United States. 

On the frontline of the epidemic of peripheral artery disease (PAD) and related 400 leg amputations per day in the U.S., Kumar Madassery, MD, director of peripheral vascular intervention and critical limb ischemia (CLI) program at Rush University Medical Center in Chicago, explains there is a glaring health inequities in rural and low income areas of the country.

Peripheral artery disease is out of control in many rural, low income communities

Peripheral artery disease (PAD) leads to more than 400 leg amputations per day in the U.S. Kumar Madassery, MD, discussed the importance of increasing awareness and reaching patients before it is too late. 

Boston Scientific’s Agent Drug-Coated Balloon (DCB), which delivers a therapeutic dose of the anti-proliferative drug paclitaxel to the patient’s scar tissue to prevent ISR from recurring, gained FDA approval on March 1..

Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB

When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing. 

Cognitive impairment among heart failure patients: How cardiologists can help

The Heart Failure Society of America shared a new scientific statement about this topic, noting that many patients may require additional help.

Thumbnail

Heart issues more common in adults who drink soda, other sweetened beverages

Diet sodas made with artificial sweeteners are associated with an even higher risk of issues than sugar-sweetened sodas.

HeartFlow FFR-CT is a non-invasive imaging method to determine the fractional flow reserve for the entire coronary tree.

AI-based CAD assessments as accurate as FFR, new 10-year study confirms

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Medicare data stethoscope healthcare trends graphs finance financials

ACC, SCAI say new funding bill did not do enough to limit Medicare reimbursement cuts to cardiology services

President Joe Biden signed a funding bill worth $460 billion on March 9, but it only included partial relief for cardiologists, cardiac surgeons and other cardiology professionals. 

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do

A new scientific statement from the American Heart Association explores the many ways AI and machine learning are being used to improve care for heart patients.